Item 8.01 Other Events

On March 28, 2022, CorMedix Inc. (the "Company") issued a press release announcing that the resubmission of the New Drug Application for DefenCath has been accepted for filing by the U.S. Food and Drug Administration.

A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits





(d) Exhibits



Exhibit No.   Description
99.1            Press Release dated March 28, 2022
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)




                                       1

© Edgar Online, source Glimpses